Recombinant CALCA, CALCB (Fremanezumab Biosimilar) antibody

Catalog No. ABIN7597700

This anti-CALCA, CALCB (Fremanezumab Biosimilar) antibody is a Humanized Chimeric antibody detecting CALCA, CALCB (Fremanezumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant CALCA, CALCB (Fremanezumab Biosimilar) antibody (ABIN7597700)

Target: CALCA, CALCB (Fremanezumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CALCA, CALCB (Fremanezumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CALCA, CALCB (Fremanezumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Fremanezumab Biosimilar Antibody

Specificity: CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CALCA, CALCB (Fremanezumab Biosimilar)

Target: CALCA, CALCB (Fremanezumab Biosimilar)

Alternative Name: Fremanezumab Biosimilar

Target Type: Biosimilar

Background: CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP

UniProt: P01258, P10092

CAS-No: 1655501-53-3